MacroLensNP नेपालीने Sign in Create accountSign up
Free · Non-Life Insurance

HEI Himalayan Everest Insurance Limited

Rs 444.30 +0.90 (+0.20%) as of 2026-11-06 15:00:00
Open
442.00
High
444.40
Low
437.00
Prev. close
443.40
Volume
7,303
Turnover
32.45 lakh
Avg volume (30 d)
27,946
52-week low Rs 418.00
high Rs 596.00 -25.5% from the 52-week high

Himalayan Everest Insurance Limited (HEI) is listed on the Nepal Stock Exchange in the Non-Life Insurance sector. Its share price is Rs 444.30 as of 6 November 2026, 25.5% below its 52-week high of Rs 596.00 and 6.3% above its 52-week low of Rs 418.00. It trades at a P/E of 32.9 on earnings per share of Rs 13.51, cheaper than the Non-Life Insurance sector's median P/E of 87.1.

HEI paid a dividend in 4 of the last 4 fiscal years we track; the latest was 8.00% cash for FY 2081/2082. Promoters hold 51% of the shares and the public 49%.

Key figures latest report 2082/2083 Q4

Market value
1,111 crore · 11.11 arba
Shares listed
25,001,574
Paid-up capital
250.02 crore · 2.50 arba
EPS (annualised)
Rs 13.51
P/E
32.9
Book value / share
Rs 213.94
P/B
2.08
ROE
6.3%
ROA
3.15%
Dividend yield
1.80%
Net profit (annualised)
33.79 crore
Reserves
–
Total assets
1,073 crore · 10.73 arba
Debt to equity
1.01

Quarter by quarter trailing 12 months at each quarter

QuarterEPSEPS growth (y/y)Net profitRevenueROE
2082/2083 Q4 13.51 -36.5% 33.79 crore 484.62 crore · 4.85 arba 6.5%
2082/2083 Q3 12.42 -21.1% 31.05 crore 419.26 crore · 4.19 arba 6.0%
2082/2083 Q2 15.53 -39.7% 38.82 crore 423.00 crore · 4.23 arba 7.5%
2082/2083 Q1 14.27 -47.6% 35.68 crore 366.96 crore · 3.67 arba 6.9%
2081/2082 Q4 21.29 -20.3% 53.23 crore 409.53 crore · 4.10 arba 10.5%
2081/2082 Q3 15.75 -49.3% 39.38 crore 417.21 crore · 4.17 arba 7.9%
2081/2082 Q2 25.74 +36.2% 64.35 crore 456.28 crore · 4.56 arba 13.3%

Dividends

Fiscal yearBonusCashBook close
2081/2082– 8.00% 5 Jan 2026
2080/2081– 8.75% 27 Feb 2025
2079/20808.63% 6.37% 28 Jan 2024
2078/20792.75% 0.14% 17 Mar 2023

Bonus / right shares: Jan 2024 Bonus share 8.6% · Mar 2023 Bonus share 2.9%

Who owns it

Promoters 51% Public 49%
Public float
12,250,773 shares
Mutual funds hold
7.4% of the float
Promoter lock-in
–

MacroLens analysis of HEI

More on HEI on the full desk The rating and verdict, fair value, dump risk and warning signs, the 12-month target, the buy / sell meter with every past signal, cornering and broker activity - the analysis behind every number above. Create an account - 7-day trial

Other Non-Life Insurance companies

CompanyPriceTodayP/EP/BMarket value
RBCL Rastriya Beema Company Limited 14,200.00 +3.42% 109.92.22 3,786 crore · 37.86 arba
SPIL Siddhartha Premier Insurance L... 607.00 +0.51% 52.12.33 1,704 crore · 17.04 arba
SICL Shikhar Insurance Co. Ltd. 532.60 -0.26% 127.12.77 1,652 crore · 16.52 arba
NIL Neco Insurance Co. Ltd. 517.10 -0.46% 49.72.28 1,434 crore · 14.34 arba
SALICO Sagarmatha Lumbini Insurance C... 523.00 +0.67% 43.82.25 1,372 crore · 13.72 arba
NLG NLG Insurance Company Ltd. 495.00 +0.41% 228.12.98 1,321 crore · 13.21 arba
IGI IGI Prudential Insurance Compa... 389.20 -1.09% 2,993.82.17 1,179 crore · 11.79 arba
NICL Nepal Insurance Co. Ltd. 435.60 -0.77% 87.12.46 1,110 crore · 11.10 arba

Every Non-Life Insurance company 13

Browse all NEPSE stocks by sector →

HEI: common questions

What is the share price of HEI today?

HEI (Himalayan Everest Insurance Limited) closed at Rs 444.30 as of 6 November 2026 on NEPSE.

Does HEI pay dividends?

HEI paid a dividend in 4 of the last 4 fiscal years we track; the latest was 8.00% cash for FY 2081/2082.

What is the P/E ratio of HEI?

It trades at a P/E of 32.9 on earnings per share of Rs 13.51, cheaper than the Non-Life Insurance sector's median P/E of 87.1.

Is HEI a good buy?

This page is not buy or sell advice. MacroLens NP rates every NEPSE company on its fundamentals - HEI's rating, fair value, dump risk and broker activity are on the desk, free for 7 days.

Prices from NEPSE; figures from the company's quarterly reports; dividends, ownership and news from public filings. Research, not a recommendation to buy or sell - see the risk disclosure.